Botbol V, Scornik O A
Proc Natl Acad Sci U S A. 1979 Feb;76(2):710-3. doi: 10.1073/pnas.76.2.710.
Incubation of intact mouse reticulocytes with bestatin (a competitive inhibitor of aminopeptidases) produced the accumulation of low molecular weight intermediates in the degradation of puromycinyl-peptides or analog-containing proteins that had been pulse labeled with L-[1-14C]leucine. A large fraction of the radioactive protein was degraded to trichloroacetic acid-soluble products within 10 min. In the presence of bestatin (0.5 mg/ml), one-fourth of these products appeared to be dipeptides, tripeptides, or both: they were resistant to ninhydrin at acid pH (a treatment that decarboxylates only free amino acids) except after intensive acid hydrolysis, and they eluted from a Sephadex G-10 column with an apparent average size of 300 daltons. These radioactive products did not appear if incorporation of the tracer was prevented by prior treatment with cycloheximide, demonstrating that they originated from polypeptide precursors. Thus, a peptidase inhibitor has been successfully used in the production of low molecular weight intermediates in the in vivo degradation of cellular proteins.
用贝司他汀(一种氨肽酶竞争性抑制剂)孵育完整的小鼠网织红细胞,会使用L-[1-¹⁴C]亮氨酸脉冲标记的嘌呤霉素基肽或含类似物的蛋白质降解过程中积累低分子量中间体。大部分放射性蛋白质在10分钟内降解为三氯乙酸可溶性产物。在贝司他汀(0.5mg/ml)存在的情况下,这些产物中有四分之一似乎是二肽、三肽或两者皆有:它们在酸性pH值下对茚三酮有抗性(该处理仅使游离氨基酸脱羧),除非经过强烈酸水解,并且它们从葡聚糖G-10柱上洗脱时的表观平均大小为300道尔顿。如果先用环己酰亚胺处理以阻止示踪剂掺入,则不会出现这些放射性产物,这表明它们起源于多肽前体。因此,一种肽酶抑制剂已成功用于体内细胞蛋白质降解过程中低分子量中间体的产生。